omniture
NeuroXT Inc.

Latest News

NeuroXT Inc. Receives U.S. FDA 510(k) Clearance for NEXT-Cue, AI Software Supporting Prognostic Assessment in Mild Cognitive Impairment

* Supports clinicians in assessing progression from mild cognitive impairment to Alzheimer's deme...

2026-10-20 20:00 1997